MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202547068242 A) filed by Diogenx; Institut National De La Sante Et De La Recherche Medicale; Centre National De La Recherche Scientifique; and Universite Cote D'Azur, Marseille, France, on July 17, for 'recombinant variants of r-spondin proteins and their use.'
Inventor(s) include Collombat, Patrick; and Botti, Paolo.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to recombinant variants of R-spondin proteins and their use as a medicament, in particular for the treatment of diabetes."
The patent application was in...